Digipath
Home > Boards > US OTC > Medical - Equipment > Arrayit Corporation (ARYC)

Arrayit Corp (ARYC) is confident that the finger

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Ace508 Member Profile
Member Level 
Followed By 59
Posts 4,830
Boards Moderated 0
Alias Born 12/08/16
160x600 placeholder
Arrayit Corporation Announces Allergy Testing Services Agreement with a Major Health and Wellness Provider GlobeNewswire Inc. - 12/3/2018 5:30:00 AM
Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health GlobeNewswire Inc. - 11/19/2018 5:30:00 AM
Arrayit Corporation Announces Brands Expansion of Proprietary Finger Stick Allergy Testing GlobeNewswire Inc. - 11/5/2018 5:30:00 AM
Arrayit Corporation and TeleChem International Inc Celebrate 25 Years in Business GlobeNewswire Inc. - 11/1/2018 5:30:00 AM
Arrayit Corporation Launches Patient Data Solutions Allergy Testing Portal for Doctors and Clinics GlobeNewswire Inc. - 10/22/2018 5:30:00 AM
Arrayit Corporation Aces Three Consecutive Rounds of Proficiency Testing with the College of American Pathologists GlobeNewswire Inc. - 10/8/2018 5:30:00 AM
Arrayit Corporation Ships Clinical Instrumentation and Software to the United States Food and Drug Administration GlobeNewswire Inc. - 9/24/2018 5:30:00 AM
Arrayit Corporation Approved for Direct Medicare Billing by the Centers for Medicare and Medicaid Services GlobeNewswire Inc. - 9/10/2018 5:30:00 AM
Arrayit Corporation Announces Allergy Testing Partnerships with Major Allergy Therapeutics Providers GlobeNewswire Inc. - 8/27/2018 5:30:00 AM
Arrayit Corporation Receives Approval for In-Store Promotions by a Major Retail Chain GlobeNewswire Inc. - 8/13/2018 5:30:00 AM
Arrayit Corporation Signs Allergy Testing Contracts with a Nationwide Consortium of Medical Clinics GlobeNewswire Inc. - 7/30/2018 5:30:00 AM
Arrayit Corporation Reports Clinical Instrumentation Sale to the United States Food and Drug Administration GlobeNewswire Inc. - 7/16/2018 5:30:00 AM
Arrayit Corporation Completes Allergy Testing Pilot Program for One of the Nation’s Largest Retail Chains GlobeNewswire Inc. - 7/2/2018 5:30:00 AM
Arrayit Corporation Announces Nationwide Allergy Testing Sales and Distribution Network GlobeNewswire Inc. - 6/18/2018 5:30:00 AM
Arrayit Corporation Achieves Testing Accuracy Required for Medicare and Medicaid Reimbursement GlobeNewswire Inc. - 5/30/2018 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 5/9/2018 1:55:34 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 3/22/2018 2:12:50 PM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 3/19/2018 6:37:10 PM
Ace508 Member Level  Sunday, 01/13/19 05:54:11 PM
Re: GM5 post# 117226
Post # of 117746 
Arrayit Corp (ARYC) is confident that the finger stick microarray immunoassays technology will receive FDA approval. This technology, proven to be accurate by College of American Pathologists, will be the first of its kind to be utilized for clinical purposes... For accurately testing allergy symptoms.

Many shareholders have received emails stating that the plan is for the company to up-list to NASDAQ this year.


Arrayit provides 7/2/18 FDA update: (1) excellent meeting, (2) large attendance by FDA top brass, (3) insightful and instructive, (4) our entire clinical team wishes to thank the agency for their feedback and generosity, and (5) we believe that our test will receive FDA approval.
https://twitter.com/arrayit/status/1014171600051007488


Arrayit senior management receives NASDAQ and NYSE up-listing proposal from small and mid-cap consulting experts http://uplisting.com focusing on growth companies seeking to improve and enhance shareholder value by listing on a major stock exchange http://www.uplisting.com



https://www.investopedia.com/ask/answers/nasdaq-listing-requirements/

Listing Requirements for All Companies

Each company must have a minimum of 1,250,000 publicly traded shares upon listing, excluding those held by officers, directors or any beneficial owners of more than 10% of the company.

In addition, the regular bid price at time of listing must be $4.00, and there must be at least three market makers for the stock.

However, a company may qualify under a closing price alternative of $3.00 or $2.00 if the company meets varying requirements.

Each listing firm is also required to follow Nasdaq corporate governance rules 4350, 4351 and 4360.

Companies must also have at least 450 round lot (100 shares) shareholders, 2,200 total shareholders, or 550 total shareholders with 1.1 million average trading volume over the past 12 months

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist